Edition:
United Kingdom

Krystal Biotech Inc (KRYS.OQ)

KRYS.OQ on NASDAQ Stock Exchange Capital Market

10.21USD
19 Apr 2018
Change (% chg)

$0.14 (+1.39%)
Prev Close
$10.07
Open
$10.01
Day's High
$10.48
Day's Low
$10.01
Volume
663
Avg. Vol
3,704
52-wk High
$11.98
52-wk Low
$8.03

Chart for

About

Krystal Biotech, Inc. is a gene therapy company. The Company is engaged in developing and commercializing novel treatments for patients suffering from dermatological diseases. The Company has developed a Skin TARgeted Delivery platform, or STAR-D platform, that consists of a patent pending engineered viral vector based on herpes... (more)

Overall

Beta: --
Market Cap(Mil.): $86.32
Shares Outstanding(Mil.): 8.68
Dividend: --
Yield (%): --

Financials

  KRYS.OQ Industry Sector
P/E (TTM): -- 84.02 32.74
EPS (TTM): -0.25 -- --
ROI: -- 1.58 14.38
ROE: -- 2.41 16.07

BRIEF-Krystal Biotech reports qtrly loss per share $1.26‍​

* Krystal Biotech reports that KB103 received clearance from RAC review and announces third quarter 2017 financial results

13 Nov 2017

BRIEF-Krystal Biotech says KB103 granted orphan drug designation by FDA

* Krystal Biotech’s KB103 granted orphan drug designation by the FDA to treat patients with dystrophic epidermolysis bullosa

07 Nov 2017

Earnings vs. Estimates